In 2015, NICE said that BioMarin's Vimizim could be used to treat patients with the ultra-rare disease Morquio A syndrome ... Given by intravenous infusion once a week, Vimizim replaces the ...
The disorder results in a buildup of mucopolysaccharides and irreversible damage to bones and organs. Lin said that people with MPS IVA, also known as Morquio syndrome, usually have a life expectancy ...
MPS II (Hunter Syndrome), MPS IV (Morquio Syndrome), and Osteogenesis Imperfecta preventive oral health services to complement the PhilHealth Konsulta package improved coverage for Peritoneal Dialysis ...